Citarinostat is under investigation in clinical trial NCT02886065 (A Study of PVX-410, a Cancer Vaccine, and Citarinostat +/- Lenalidomide for Smoldering MM).
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.